ANTI‐TUMOR ACTIVITY OF DARATUMUMAB, A NOVEL HUMAN ANTI CD38 MONOCLONAL ANTIBODY, IN IN VITRO AND IN VIVO MODELS OF B‐CELL NON‐HODGKIN LYMPHOMA. (June 2017) - Pérez‐Galán, P.; Vidal‐Crespo, A.; Matas‐Céspedes, A.; Rodriguez, V.; Rossi, C.; Roué, G.; López‐Guillermo, A.; Giné, E.; Campo, E.; Colomer, D.; Wiestner, A.; Bezombes, C.; et al.